BioCentury
ARTICLE | Finance

Big return for ND Capital on point-of-care CAR T player CellPoint

With other investors failing to see product opportunity, VC parlays small bet into ‘brilliant’ return with Galapagos takeout

June 22, 2022 10:14 PM UTC

Three years after making its initial, €7 million investment, ND Capital has made what the firm’s Dani Bach called a “brilliant” return on CellPoint as its lone investor after Galapagos bought the Dutch CAR T player.

On Tuesday, Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG) announced it acquired CellPoint B.V. for €125 million ($131.3 million), plus up to €100 million in milestones...